胸膜间皮瘤

  • 网络pleural mesothelioma;MPM;mesothelioma of pleura
胸膜间皮瘤胸膜间皮瘤
  1. 在胸膜间皮瘤之后,腹膜间皮瘤在其它诊断中占多数。

    After pleural mesothelioma , peritoneal mesothelioma accounts for the majority of other diagnoses .

  2. 本质上,当石棉纤维被吸入并在肺内或周围持续存在使得胸膜间皮瘤发展。

    In essence though , pleural mesothelioma develops when jagged asbestos fibers are inhaled and settle in and around the lungs .

  3. 实验性大鼠胸膜间皮瘤病理改变与CT表现的研究

    Study of Pathological Change and CT Manifestation in Experimental Rats ' Malignant Pleural Mesothelioma

  4. 方法:对12例经病理证实的悲性胸膜间皮瘤行CT导引下经皮穿刺瘤灶内注射~(32)P&碘油乳剂,单次注射4例,多次注射8例;

    Methods 12 patients with malignant pleural mesothelioma proven by pathology were treated using percutaneous injection of 32P - lipidol , single injection was done in 4 cases ;

  5. 目的:探讨胸膜间皮瘤CT影像形成的病理基础以及CT对本病的诊断价值。

    Objective To evaluate the correlation between the CT findings of mesothelioma and pathologic changes , and determine the usefulness of CT in the differential diagnosis of pleural diseases .

  6. 结论:N2期对于恶性胸膜间皮瘤患者的预后有着负性的影响。

    CONCLUSIONS : The presence of N2 disease negatively affects the prognosis of patients with malignant pleural mesothelioma .

  7. 恶性胸膜间皮瘤(malignantpleuralmesotheliomaMPM)是一种少见肿瘤,但发病率有逐年增高趋势。

    Malignant pleural mesothelioma ( MPM ) is a rare tumor , however , its morbidity is increasing in recent years .

  8. 培美曲塞二钠是唯一治疗恶性胸膜间皮瘤(MPM)的药物。

    Pemetrexed disodium is the only agent for the treatment of malignant pleural mesothelioma ( MPM ) .

  9. 目的观察培美曲塞(抗癌药)联合铂类制剂治疗恶性胸膜间皮瘤(MPM)的疗效与安全性。

    Objective To evaluate the efficacy and satety of pemetrexed combined with platinum complexes in the treatment of malignant pleural mesothelioma ( MPM ) .

  10. 方法老年VATS42例,占同期VATS的31.8%,年龄60~82岁,病种主要有自发性气胸、肺癌、脓胸、胸膜间皮瘤等。

    The patients ranged in age from 60 to 82 years , and were mainly ill with spontaneous pneumothorax , lung cancer , purulent pleurisy , pleural mesothelioma .

  11. 21例胸膜间皮瘤误诊原因探讨

    The analyses of misdiagnosis reasons in 21 cases of pleural mesothelioma

  12. 目的评价胸腔镜检查对胸膜间皮瘤的诊断价值。

    Objective To assess the diagnosis of thoracoscopy in pleural mesothelioma .

  13. 局限性胸膜间皮瘤18例临床分析

    Clinical Analysis of 18 Patients with Localized Mesothelioma of the Pleura

  14. 局限型胸膜间皮瘤四例报告及文献复习

    Localized Pleural Mesothelioma-Report of Four Cases and Review of Literature

  15. 诱发性大鼠恶性胸膜间皮瘤病理形态学研究

    Pathological changes of rat malignant pleural mesothelioma induced by asbestos

  16. 温热联合细胞周期特异性药物对恶性胸膜间皮瘤细胞的影响

    Effects of Hyperthermia Combined Cell Cycle Specific agents on Malignant Pleural Mesothelioma

  17. 恶性胸膜间皮瘤&附10例临床分析

    MALIGNANT PLEURAL MESOTHELIOMA & An analysis of 10 patients

  18. 本文报告经病理证实的29例胸膜间皮瘤和1例心包间皮瘤。

    Thirty cases of mesothelioma , 29 pleural and1 pericardial , are reported .

  19. 赵远红辨治恶性胸膜间皮瘤验案1则

    Successful Treatment of One Case of Malignant Pleural Mesothelioma

  20. 石棉诱发大鼠胸膜间皮瘤的形态发生学观察

    Observation of the Morphological Genesis of Pleural Mesothelioma Induced by Asbestos in Rats

  21. 石棉肺合并恶性胸膜间皮瘤1例

    A case of malignant pleural mesothelioma complicated by asbestosis

  22. 可弯曲内科胸腔镜在胸膜间皮瘤诊断中的价值

    Value of flexi-rigid medical thoracoscopy in diagnosing pleural mesothelioma

  23. 局限型胸膜间皮瘤1例报告

    One Case : Pleural Mesothelioma : Focal Type

  24. 胸腔镜术对胸膜间皮瘤的诊断价值

    The diagnostic value of thoracoscopy in pleural mesothelioma

  25. 青石棉诱发大鼠胸膜间皮瘤的实验研究

    Mesothelioma in Rats Following Intrapleural Injection of Crocidolite

  26. 恶性胸膜间皮瘤的影像学鉴别诊断

    Imaging Differentiation of Malignant Pleural Mesothelioma

  27. 恶性胸膜间皮瘤的实验模型

    Experiment models of malignant pleural mesothelioma

  28. 培美曲塞联合铂类制剂治疗恶性胸膜间皮瘤的有效性与安全性

    Efficacy and safety of pemetrexed combined with platinum complexes in the treatment of malignant pleural mesothelioma

  29. 人恶性胸膜间皮瘤细胞培养方法的研究及胸膜外动物模型的建立

    The Research of Cell Culture-method and the Outside-pleural-membrane Animal Model Establishment of Human Malignant Pleural Mesothelioma

  30. 目的提高对胸膜间皮瘤X线诊断价值的认识。

    Objective To deepen the understanding of the value of X-ray in the diagnosis of pleural mesothelioma .